adherence depressive symptoms disclosure concerns hiv stigma stigmatization ie social discrediting and devaluation due to hiv status may interfere with disease management among persons living with hiv plwha through associations with disclosure concerns and depressive symptoms this study tested the hypotheses that disclosure concerns and depressive symptoms would mediate the association of stigma to treatment adherence medication and clinic appointment adherence in an outpatient sample of plwha n  174 47 white 41 african-american participants completed measures of stigma-related experiences concerns about disclosing hiv status depression and medication adherence chart data were obtained to characterize clinic appointment attendance in the first set of analyses simple mediation models indicated that disclosure concerns mediate the association between stigma and medication adherence   -0097 95 ci -0212 to -0003 but not the association between stigma and clinic attendance in the next set of analyses depressive symptoms were shown to mediate both the stigma-medication adherence association   -0113 95 ci -0232 to -0034 and the stigma-clinic attendance association   0397 95 ci 0172 to 0723 to augment these analyses serial mediation models tested the serial effect of disclosure concerns on depressive symptoms in the stigma-treatment adherence association the serial mediation analyses were significant   -0025 95 ci -0068 to -0004 for medication adherence   0118 95 ci 0039 to 0237 for clinic attendance providing evidence that stigmatizing experiences are negatively associated with medication adherence and missed clinic appointments indirectly through the serial effect of disclosure concerns on depressive symptoms disclosure concerns and depressive symptoms are two mechanisms worthy of further research to enhance our understanding of the association between hiv stigma and treatment adherence